Eli Lilly Shares (Diluted) decreased by 0.3% to 895.9M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.5%, from 900.6M to 895.9M. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to basic shares indicates a higher reliance on equity-based compensation or convertible debt financing.
Weighted-average shares outstanding (diluted) includes the total number of basic common shares plus all additional share...
Commonly compared against basic shares to determine the 'dilution overhang' present in a company's capital structure.
weighted_shares_diluted| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 910.4M | 910.8M | 906.4M | 902.9M | 903.8M | 903.3M | 902.7M | 899.8M | 903.8M | 904.2M | 905M | 900.6M | 899.8M | 898.8M | 895.9M |
| QoQ Change | — | +0.0% | -0.5% | -0.4% | +0.1% | -0.1% | -0.1% | -0.3% | +0.4% | +0.0% | +0.1% | -0.5% | -0.1% | -0.1% | -0.3% |
| YoY Change | — | — | — | -0.8% | -0.8% | -0.3% | -0.0% | -0.4% | +0.1% | +0.2% | +0.6% | -0.4% | -0.5% | -0.7% | -0.5% |